Goodpasture syndrome is severe renal disease associated with pulmonary hemorrhage mediated by autoantibodies against glomerular basement membrane (GBM).  Chondrex provides unique rat monoclonal antibodies against non-collagenase domain 1 (NC1) of type IV collagen of GBM, which induces nephritis similar to Goodpasture syndrome in rats.